Skip to content
10-K

Annual Report

BIOPLUS LIFE CORP

0001493152-21-026939

← back to feed
Filed
Nov 2, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Nov 2, 2021 362.91M sh
Capex FY 2020 · Dec 31, 2019 $58.56K
Operating Cash Flow FY 2020 · Dec 31, 2019 −$146.85K
Cash And Equivalents FY 2020 · Dec 31, 2019 $210.74K
Current Liabilities FY 2020 · Dec 31, 2019 $782.81K
Total Liabilities FY 2020 · Dec 31, 2019 $1.47M
Current Assets FY 2020 · Dec 31, 2019 $989.71K
Total Assets FY 2020 · Dec 31, 2019 $3.21M
Sga Expense FY 2020 · Dec 31, 2019 $855.27K
Net Income FY 2020 · Dec 31, 2019 −$93.19K
Operating Income FY 2020 · Dec 31, 2019 −$59.9K
Gross Profit FY 2020 · Dec 31, 2019 $807.47K
Cost Of Revenue FY 2020 · Dec 31, 2019 $914.74K
Revenue FY 2020 · Dec 31, 2019 $1.72M
Stockholders Equity FY 2020 · Dec 31, 2018 $1.8M